Tag: Novartis
Novartis offers 2.7 billion euros for Munich biotech company Morphosys – Economy
The Swiss pharmaceutical company Novartis is reaching out to the biotech company Morphosys. The Swiss are spending 2.7 billion euros on this. Novartis is particularly interested in the promising pelabresib…
Novartis prepares spin-off from Sandoz – Economy
The Swiss pharmaceutical company Novartis is taking the last big step in its almost ten-year-long corporate restructuring seriously: the generics subsidiary Sandoz is to be spun off on October 4…
Novartis and Roche will not have to pay their record fine of more than 400 million euros
A record fine of more than 400 million euros pronounced against the Swiss laboratories Novartis and Roche by the Competition Authority has been canceled by the Paris Court of Appeal,…
Novartis is remodeling: can the plan work? – Business
Considering that a new era is about to begin for Novartis this year, the pharmaceutical company presents itself quite soberly on this February morning. CEO Vas Narasimhan, who took office…
Novartis is rebuilding – economy
Considering that a new era is about to begin for Novartis this year, the pharmaceutical company presents itself quite soberly on this February morning. CEO Vas Narasimhan, who took office…
Pharma: Novartis wants to list Sandoz on the stock exchange – Economy
The Swiss pharmaceutical company Novartis wants to make its generics subsidiary Sandoz independent. The company Novartis from Basel announced that the business with the copycat drugs should be split off…
Pharmaceutical industry – Novartis cuts jobs – economy
The restructuring of the Swiss pharmaceutical giant Novartis will cost a good seven percent of the workforce the job. In the course of the realignment of the main business with…
Restructuring – Novartis is apparently cutting thousands of jobs – economy
The pharmaceutical company Novartis wants to cut jobs. Thousands of jobs are affected worldwide, he reports Tages-Anzeiger citing insiders. In Switzerland alone, a three-digit number of jobs are likely to…
Pharmaceutical industry – Novartis triples profit – Economy
– The Swiss pharmaceutical company Novartis tripled its profit in 2021 to $24.02 billion thanks to the sale of its multi-billion dollar Roche stake and plans to raise the dividend…
Novartis – Roche buys back shares – Economy
The dissolution of the links between the two Swiss pharmaceutical groups Roche and Novartis is fixed. The Roche shareholders with voting rights voted at an Extraordinary General Meeting for the…